Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics - Wikidata - awgldk - TriplyDB

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

http://www.wikidata.org/entity/Q28376754

about

Recent advances in the management of asthma using leukotriene modifiers Asthma, airway biology, and allergic rhinitis in AJRCCM 2000.Adenosine monophosphate bronchial provocation and the actions of asthma therapy.Leukotrienes and airway inflammation Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies Investigative bronchoprovocation and bronchoscopy in airway diseases Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.Using guinea pigs in studies relevant to asthma and COPD.Expanding roles for leukotrienes in airway inflammation.Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.Combination therapy with anti-mediator drugs in allergic disease.SCF-induced airway hyperreactivity is dependent on leukotriene production.A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.Interleukin-2-induced increased airway responsiveness and lung Th2 cytokine expression occur after antigen challenge through the leukotriene pathway.Overview of animal models of asthma.Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor.Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.

P2860

Q28166742-49A63E6E-B944-4E8E-AE61-E27FFFE48EB4 Q34446626-D101EEFB-5AC3-4905-B80E-8A0BFAB565D3 Q35076739-043793B6-CF90-413E-BB92-7612A27B486B Q35106124-B9808A3E-5134-44DB-8BC6-B0C857425F36 Q35648173-41E34CD3-14FB-4974-8AC8-1D8B47879C64 Q36195439-1E1F0E74-8643-49E7-AFBC-7747FE545297 Q36774177-E0C82477-4C36-4E2B-ABBF-17C316D1DC80 Q37157003-E543221E-A3AF-47F7-8AAA-CD627E680AE2 Q37208991-A9F8C35E-28A4-45B7-8665-BBA0AE444BB1 Q39756267-9F6AA250-704A-4694-8AEB-67E3BCA8EDDC Q40059650-BF0EC4A4-0E36-48CA-A93A-D1D3CD0D57C6 Q43522675-9FBE543B-0D65-4E79-8598-D90C7D153F1A Q43606161-C710EEF9-8B75-4A38-B4D0-629B276CC740 Q43612606-819F956B-E863-444C-8496-47425D4AA779 Q44014999-A7095304-770B-4918-87CD-3EFCB734F4E8 Q46342761-1940DD3A-3F39-4782-AD26-11F8C7A86BCD Q46814500-F7A4B7CA-15A7-4ED5-9388-8E893A5AAB45 Q47709182-D70B0BA8-46D6-45D3-867D-E3902CBB3A23

P2860

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

http://www.wikidata.org/entity/Q28376754

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@ast

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@en

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@nl

type

label

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@ast

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@en

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@nl

prefLabel

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@ast

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@en

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@nl

P1433

Q28376754-91E6A26E-2056-4E55-BD8F-E507D42640FF

P1476

Q28376754-02F0B77C-9C34-4136-8F54-4E6B5D2C5B7C

P2093

Q28376754-14C9BDFB-46E0-42AD-B42B-CA46245ED555

Q28376754-14E68C2E-8EDD-400A-8194-FD5852B9708F

Q28376754-3A9F0CE6-A631-4DBB-951D-36A2CD34EA95

Q28376754-7A5AAF9E-924F-4355-90EA-6F9425868DF0

Q28376754-9C3CE1BE-BC29-4F78-9595-59D878BF8F48

Q28376754-B50EFC09-5BD0-474B-9D2A-D931074B1564

Q28376754-F701A193-03BA-4019-AA82-5ED181882935

Q28376754-FEFD76DE-1B6A-44F6-89DD-20458290BF5C

P2860

Q28376754-0FCA954E-A342-488F-93EA-10E76030C8A7

Q28376754-2A1C3D2F-D96A-4FED-80DF-83B4542315BF

Q28376754-313861E9-FB18-43D7-AEAE-C1B3E04B8442

Q28376754-5AB95FAE-DC92-4EB4-9F28-1BF936F091AB

Q28376754-68607ED4-2706-494B-AF20-C2D0C6291E26

Q28376754-86575BC3-7F71-46CE-9920-64EE49283A0A

Q28376754-9189C564-24FE-4EE0-AFAA-C18330639E06

Q28376754-D68D297F-6EC1-4654-8214-8E29205B0802

Q28376754-E0E1FADE-0411-49B6-892B-AD9CED63D7F8

Q28376754-EA9A5B2F-D815-405A-8695-6F77A446CD5E

P304

Q28376754-17D65273-5E4F-43D4-A732-56AB3ADA6487

P31

Q28376754-F5037EA3-6563-4020-84B4-1BFA8A881531

P356

Q28376754-E91E4B58-9BDB-4050-9E6A-956E660DC8B2

P407

Q28376754-48515186-0F6D-4AFE-8D80-390B7902EAFE

P433

Q28376754-17349F09-2029-4194-9C87-866FB78A3B4F

P478

Q28376754-AD5C1935-A0A6-451A-B8BE-9BC39F70A98D

P577

Q28376754-41265843-5C4A-47C9-B66D-2248C2B25640

P698

Q28376754-3FFB8EA7-83A7-4FE2-B63C-571717080C54

P921

Q28376754-2A02C2E4-BA7F-46F3-94C9-3DC08A769B2B

Q28376754-FC2537FE-0466-41E7-9A00-1E641092FF9E

P356

AJRCCM.161.4.9904026

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

@en

P2093

C Lanni

http://www.w3.org/2001/XMLSchema#string

E R Bleecker

http://www.w3.org/2001/XMLSchema#string

J D Hasday

http://www.w3.org/2001/XMLSchema#string

J R Hebel

http://www.w3.org/2001/XMLSchema#string

L M Dubé

http://www.w3.org/2001/XMLSchema#string

P Wisniewski

http://www.w3.org/2001/XMLSchema#string

S S Meltzer

http://www.w3.org/2001/XMLSchema#string

W C Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Human alveolar macrophages produce leukotriene B4

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.

The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep.

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions.

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.

Cytokines in symptomatic asthma airways.

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

Treatment of asthma with drugs modifying the leukotriene pathway.

P304

1229-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.161.4.9904026

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10764316

http://www.w3.org/2001/XMLSchema#string

P921